Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Indaptus Therapeutics ( (INDP) ) has issued an update.
On January 8, 2026, Indaptus Therapeutics, Inc. expanded its Board of Directors from eight to nine members and appointed David Natan as a Class II director, with a term running until the 2026 annual meeting of stockholders. Natan, designated under a December 22, 2025 securities purchase agreement by investor David E. Lazar, brings extensive executive, financial, and public company board experience, including leadership roles in consulting, energy, pharmaceuticals, technology, and prior tenure at Deloitte & Touche. He was simultaneously named to the Audit Committee, replacing Avraham Ben-Tzvi in that role, while Ben-Tzvi will remain on the Board as a director and is expected to serve as a paid consultant, and the Board has determined that Natan meets Nasdaq’s independence and heightened audit committee independence requirements and will be compensated under the company’s non-employee director compensation plan.
The most recent analyst rating on (INDP) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Indaptus Therapeutics stock, see the INDP Stock Forecast page.
Spark’s Take on INDP Stock
According to Spark, TipRanks’ AI Analyst, INDP is a Neutral.
The score is primarily held down by weak financial performance (pre-revenue, persistent losses, and negative cash flow alongside shrinking assets/equity). Technicals are only modestly supportive with mixed trend signals, and valuation metrics provide limited support due to negative earnings and no dividend yield data.
To see Spark’s full report on INDP stock, click here.
More about Indaptus Therapeutics
Indaptus Therapeutics, Inc. operates in the biopharmaceutical sector, focusing on developing therapeutics, with governance overseen by a Board of Directors that includes independent members and an Audit Committee responsible for financial oversight and compliance with Nasdaq listing standards.
Average Trading Volume: 707,444
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.54M
See more data about INDP stock on TipRanks’ Stock Analysis page.